Literature DB >> 20482773

OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.

Alexandre Manirakiza1, Emmanuella Picard, Richard Ngbale, Didier Menard, Ionela Gouandjika-Vasilache.   

Abstract

BACKGROUND: Humans are the only host of polioviruses, thus the prospects of global polio eradication look reasonable. However, individuals with immunodeficiencies were shown to excrete vaccine derived poliovirus for long periods of time which led to reluctance to prolong the vaccination campaign for fear of this end result. Therefore, we aimed to assess the duration of excretion of poliovirus after the 2001 National Immunization Days according to Human immunodeficiency virus status.
FINDINGS: Fifty three children were enrolled. Sequential stool samples were collected in between National Immunisation Days rounds and then every month during one year. Children were classified into 2 groups: no immunodepression (n = 38), immunodepression (n = 15) according to CD4+ lymphocytes cells count. Thirteen poliovirus strains were isolated from 11 children: 5 Human immunodeficiency virus positive and 6 Human immunodeficiency virus negative. None of the children excreted poliovirus for more than 4 weeks. The restriction fragment length polymorphism analysis showed that all strains were of Sabin origin including a unique Polio Sabine Vaccine types 2 and 3 (S2/S3) recombinant.
CONCLUSIONS: From these findings we assume that Human immunodeficiency virus positive children are not a high risk population for long term poliovirus excretion. More powerful studies are needed to confirm our findings.

Entities:  

Year:  2010        PMID: 20482773      PMCID: PMC2880960          DOI: 10.1186/1756-0500-3-136

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  19 in total

Review 1.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

Authors:  Olen M Kew; Roland W Sutter; Esther M de Gourville; Walter R Dowdle; Mark A Pallansch
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

2.  The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.

Authors:  J Balanant; S Guillot; A Candrea; F Delpeyroux; R Crainic
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

Review 3.  The biologic principles of poliovirus eradication.

Authors:  W R Dowdle; M E Birmingham
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

4.  Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.

Authors:  Dobromir N Pavlov; Walda B Van Zyl; Mariane Kruger; Liezl Blignaut; Willie O K Grabow; Marthie M Ehlers
Journal:  Diagn Microbiol Infect Dis       Date:  2005-11-14       Impact factor: 2.803

5.  No evidence of prolonged enterovirus excretion in HIV-seropositive patients.

Authors:  Ionela Gouandjika-Vasilache; Chantal Akoua-Koffi; Evelyne Begaud; Annick Dosseh
Journal:  Trop Med Int Health       Date:  2005-08       Impact factor: 2.622

6.  Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.

Authors:  D N Pavlov; W B Van Zyl; J Van Heerden; M Kruger; L Blignaut; W O K Grabow; M M Ehlers
Journal:  J Appl Microbiol       Date:  2006-12       Impact factor: 3.772

7.  Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.

Authors:  R W Ryder; M J Oxtoby; M Mvula; V Batter; E Baende; W Nsa; F Davachi; S Hassig; I Onorato; A Deforest
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

8.  Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life.

Authors:  W Borkowsky; M Rigaud; K Krasinski; T Moore; R Lawrence; H Pollack
Journal:  J Pediatr       Date:  1992-03       Impact factor: 4.406

9.  Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.

Authors:  F P Kroon; J T van Dissel; J Labadie; A M van Loon; R van Furth
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

10.  HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Authors:  Mathurin C Tejiokem; Ionela Gouandjika; Lydie Béniguel; Marie-Claire Endegue Zanga; Gilbert Tene; Jean C Gody; Elisabeth Njamkepo; Anfumbom Kfutwah; Ida Penda; Catherine Bilong; Dominique Rousset; Régis Pouillot; Frédéric Tangy; Laurence Baril
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more
  4 in total

Review 1.  Polio elimination in Nigeria: A review.

Authors:  Usman Nakakana Nasir; Ananda Sankar Bandyopadhyay; Francesca Montagnani; Jacqueline Elaine Akite; Etaluka Blanche Mungu; Ifeanyi Valentine Uche; Ahmed Mohammed Ismaila
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a new human enterovirus A71 genogroup.

Authors:  Maël Bessaud; Sylvie Pillet; Wafa Ibrahim; Marie-Line Joffret; Bruno Pozzetto; Francis Delpeyroux; Ionela Gouandjika-Vasilache
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

3.  Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.

Authors:  Stephanie B Troy; Georgina Musingwini; Meira S Halpern; Chunhong Huang; Lynda Stranix-Chibanda; Diana Kouiavskaia; Avinash K Shetty; Konstantin Chumakov; Kusum Nathoo; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

4.  Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.

Authors:  Joanne Hassan; Laura Wangai; Peter Borus; Christopher Khayeka-Wandabwa; Lucy Wanja Karani; Mercy Kithinji; Michael Kiptoo
Journal:  BMC Res Notes       Date:  2017-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.